Starling Oncology
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $169,767 | $161,282 | $147,441 | $141,957 |
Gross Profit | 29,148 | 27,165 | 23,315 | 22,765 |
EBITDA | -641 | -6,092 | 1,058 | -3,960 |
EBIT | -2,163 | -7,930 | -558 | -5,592 |
Net Income | -15,748 | -9,789 | -2,492 | -7,508 |
Net Change In Cash | 169,767 | 161,282 | 147,441 | 141,957 |
Free Cash Flow | 8,880 | 11,032 | -3,257 | 2,173 |
Cash | 36,895 | 41,094 | 30,280 | 33,565 |
Basic Shares | 1,047,283 | 103,031 | 101,801 | 101,456 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $502,729 | $393,412 | $324,239 | $252,483 |
Gross Profit | 76,435 | 53,997 | 59,573 | 52,093 |
EBITDA | -42,517 | -50,880 | -70,454 | 8,402 |
EBIT | -49,461 | -57,167 | -76,327 | 3,991 |
Net Income | -60,606 | -64,663 | -83,068 | 152 |
Net Change In Cash | 502,729 | 393,412 | 324,239 | 252,483 |
Free Cash Flow | -27,787 | -30,327 | -40,882 | -67,285 |
Cash | 33,565 | 49,669 | 33,488 | 14,010 |
Basic Shares | 92,389 | 75,737 | 74,145 | 73,265 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.13 |
2026-06-30 | -$0.08 |
2026-03-31 | -$0.02 |
2025-12-31 | -$0.06 |